Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Remimazolam on Incidence of Postoperative Nausea and Vomiting Following General Anesthesia in High-risk Patients: a Multicenter, Double-blinded, Placebo-controlled Randomized Trial

NCT04861337 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT04861337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04861337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Remimazolam on Incidence of Postoperative Nausea and Vomiting Following General Anesthesia in High-risk Patients: a Multicenter, Double-blinded, Placebo-controlled Randomized Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 19, 2021
Completion date
April 22, 2023
Enrollment
552 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

benzodiazepine, high-risk patients, postoperative nausea and vomiting